H2020FP7HORIZON
assistance publique hopitaux de paris
- Country
- FRFrance
- Defence projects
- 0
- Projects, all programmes
- 192
- As coordinator
- 6
- EU contribution (CORDIS)
- EUR 71,531,728
- Active
- 2008 to 2026
Projects
192 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| SAGHESafety and Appropriateness of Growth hormone treatments in Europe | FP7 | 2009 | Coordinator | EUR 627,312 |
| EVINCI-STUDYEvaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart Disease | FP7 | 2009 | Participant | EUR 84,513 |
| NEUROSISEfficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia | FP7 | 2009 | Participant | EUR 391,087 |
| MITOTARGETMitochondrial dysfunction in neurodegenerative diseases: towards new therapeutics | FP7 | 2009 | Participant | EUR 187,984 |
| SAFE-TSAFER AND FASTER EVIDENCE-BASED TRANSLATION | FP7 | 2009 | Participant | EUR 2,039,152 |
| NEOOPIOIDNo Pain during infancy by adapting off-patent medicines | FP7 | 2008 | Participant | EUR 281,650 |
| DECANBIONovel MS-based strategies to Discover and Evaluate Cancer Biomarkers in urine: Application to Diagnosis of Bladder Cancer | FP7 | 2008 | Participant | EUR 235,480 |
| TINNEvaluation of antibiotics (ciprofloxacin and fluconazole) for the treatment of infections in preterm and term neonates | FP7 | 2008 | Participant | EUR 705,527 |
| PENTA-LABNETPaediatric European Network Treatment AIDS Laboratory Network (PENTA LABNET) | FP7 | 2008 | Participant | EUR 130,760 |
| INNOVA-P2Pharma-Innovation - Patent-2 | FP7 | 2008 | Participant | EUR 2,100 |
| LOULLA&PHILLADevelopment of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukæmia in children | FP7 | 2008 | Participant | EUR 185,214 |
| CompanionAbleIntegrated Cognitive Assistive and Domotic Companion Robotic Systems for Ability and Security | FP7 | 2008 | Participant | EUR 361,213 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.